Since the Blood & Marrow Transplant Center’s Program began in 1977, our physicians have performed over 3,800 blood & marrow transplant procedures, making our blood & marrow transplant center home to the largest program in Ohio.
Data suggests medical professionals with this level of experience contribute to better patient outcomes. Each year nearly 400 patients are consulted at our blood & marrow transplant center for a possible blood & marrow transplant. We have a large referral base and have excellent relationships with community physicians that allows for successful continuity of care, making us a leader among blood & marrow transplant centers.
The mission of the Blood & Marrow Transplant (BMT) Program in the Taussig Cancer Institute is to provide high quality specialized patient care in a setting of education and research.
The entire BMT staff embraces the values of initiative, innovation, collaboration, confidentiality, empathy and integrity.
Patients all over the world need people like you to become a blood & marrow transplant donor.
The Blood & Marrow Transplant program offers state-of-the art therapies for autologous, allogeneic and non-myeloablative allogeneic blood & marrow transplants as treatment for cancer.
We offer multiple blood & marrow transplant options and utilize various hematopoietic progenitor cell sources to fit the clinical need of the patient.
Find a physician specialist for your unique blood & marrow transplant needs.
Hear what our patients have to say about their experiences at Cleveland Clinic.
We are dedicated to helping you face the challenges associated with your diagnosis and treatment.
Our program is driven by clinical and translational investigation.
The Blood & Marrow Transplant and Leukemia floors have units that are designed for patients with lengthy stays and compromised immune systems.
The type and severity of your disease determines what type of blood & marrow transplant you may need.
The latest news from the Blood & Marrow Transplant Program.
Appointment, after hours, and on call phone numbers.
Navneet Majhail, MD, MS has joined as director of the Blood & Marrow Transplant Program
Previously, Dr. Majhail was an adjunct associate professor in the University of Minnesota’s Blood & Marrow Transplant Program, and Medical Director of Health Services Research at the National Marrow Donor Program in Minneapolis.
Dr. Majhail’s research involves prevention and management of complications of blood and marrow transplantation. He also focuses on health policy issues such as health care disparities, quality of care, survivorship and economic issues related to transplant. He holds leadership positions with the Center for International Blood and Marrow Transplant Research, where he is the scientific director for the Late Effects and Health Policy Working Committees and their Health Services Research Program.
Music Therapy Helps Patient Through the "Blue Days"
Melinda Martin, 52, was diagnosed with leukemia in November 2012. She was discharged from Cleveland Clinic today after spending 13 days in the hospital following her second marrow transplant, but not before leaving a heartfelt message in the form of song to her caregivers. She credits music therapy for getting her through the 'blue days.'
Drs. Hamilton and Gerds join Blood & Marrow Transplant Program
Dr. Betty Hamilton received her medical degree from the University of Chicago Pritzker School of Medicine and completed her internship and residency at the Hospital of the University of Pennsylvania. She completed a hematology/oncology fellowship at Cleveland Clinic. Dr. Hamilton’s clinical and research interests are in hematopoietic stem cell transplantation for myeloid malignancies and novel strategies for the prevention and treatment of graft versus host disease.
Dr. Aaron Gerds received his medical degree from Loyola University Chicago Stritch School of Medicine. He stayed at Loyola for his internal medicine training, where he also served as chief resident and earned a graduate degree in clinical research methods. Subsequently, he moved to Seattle for fellowship training at the University of Washington and the Fred Hutchinson Cancer Research Center. Dr. Gerds' research interests relate to the integration of transplant and non-transplant therapies for disorders of blood and marrow failure, in particular the myelodysplastic syndromes and myeloproliferative neoplasms.
Thank you for sending us "Over the Edge" for Be The Match!
Be The Match, an organization that coordinates unrelated blood and marrow transplants, hosted a fundraiser to support their tissue-typing efforts. $1,000 was raised for each employee to send them "Over the Edge" of the North Facade of Tower East in Shaker Heights!
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2014 Cleveland Clinic. All rights reserved.